First-in-human studies are scheduled for 2021.46 47 Radiofrequency ablation (RFA) with the Barrx device (Medtronic, Dublin ...

One year into the U.S. launch of pulsed field ablation systems from Boston Scientific and Medtronic, doctors in a survey said they planned to use the technology in about 56% of ablation procedures ...

AUSTIN, TX, UNITED STATES, January 23, 2025 /EINPresswire / -- According to Research by SNS Insider, The MRI-guided neurosurgical ablation market ... Systems like Medtronic's Visualase and ...

Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

That leaves Medtronic, which recently called cardiac ablation a $9 billion segment, as Boston Scientific’s current rival in PFA. Boston Scientific reported a 177% increase in global ...

Medtronic’s cardiac ablation portfolio now includes two pulse field ablation (PFA) systems approved by the FDA for minimally invasive pulmonary vein isolation to treat atrial fibrillation (AFib), with ...

Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Medtronic (MDT ... pulsed field ablation, insulin pumps, and new AI-enabled functionality across medtech segments, the analyst ...

One year into the U.S. launch of pulsed field ablation systems from Boston Scientific and Medtronic, doctors in a survey said they planned to use the technology in about 56% of ablation procedures for ...

Stereotaxis said today that it has secured CE mark approval for its Magic robotically-navigated magnetic ablation catheter.

Pulsed field ablation (PFA) is a treatment for atrial fibrillation ... PFA revenue exploded in Q1 2024 after FDA approvals for Boston Scientific’s FARAPULSE and Medtronic’s PulseSelect. Over the last ...